News & Updates

Breastfeeding delivers long-term cardiometabolic benefits in offspring

In a secondary analysis of the HAPO FUS*, breastfeeding was found to be associated with lower rate of glucose metabolism disorders in the offspring; however, this association was not seen among the mothers.

Higher aspirin dose may attenuate severe pre-eclampsia risk among high-risk women with obesity

Doubling the routine aspirin dose used for pre-eclampsia prevention appears to help lower the risk of developing pre-eclampsia with severe features among high-risk pregnant women with obesity, according to the results of the open-label ASPREO trial.

Original New Drug Application Approvals by US FDA (1-15 March 2024)

Progesterone-to-estradiol ratio a promising treatment target in AUD

In adults with alcohol use disorder (AUD), high progesterone-to-estradiol ratios appear protective against problematic alcohol consumption, as shown in a study. Additionally, women with AUD may derive benefits from treatments tailored to their menstrual cycle phase.

Is a low-GI Mediterranean diet better for people with high cardiometabolic risk?

A low-glycaemic index (GI) diet, based on a Mediterranean dietary (MedDiet) pattern, provides no substantial impact on major cardiometabolic risk factors at fasting in individuals at high cardiometabolic risk when compared with a high-GI MedDiet, a study has shown.

Life quality drops then steadily improves after thyroidectomy in DTC patients

Patients with differentiated thyroid cancer (DTC) may experience a significant decline in health-related quality of life (HR-QoL) 3 months after thyroidectomy, but their HR-QoL will gradually improve and even exceed preoperative QoL by year 5, suggests a study.

High endocannabinoid, analogue levels tied to poor cardiometabolic profile in young adults

Plasma levels of endocannabinoids (eCBs) and their analogues show a significant association with greater adiposity and worse cardiometabolic profile in young adults, suggests a study.